2g69: Difference between revisions

New page: left|200px<br /> <applet load="2g69" size="450" color="white" frame="true" align="right" spinBox="true" caption="2g69, resolution 1.35Å" /> '''Structure of Unliga...
 
No edit summary
 
(14 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[Image:2g69.gif|left|200px]]<br />
<applet load="2g69" size="450" color="white" frame="true" align="right" spinBox="true"
caption="2g69, resolution 1.35&Aring;" />
'''Structure of Unliganded HIV-1 Protease F53L Mutant'''<br />


==Overview==
==Structure of Unliganded HIV-1 Protease F53L Mutant==
Mutations in HIV-1 protease (PR) that produce resistance to antiviral PR, inhibitors are a major problem in AIDS therapy. The mutation F53L arising, from antiretroviral therapy was introduced into the flexible flap region, of the wild-type PR to study its effect and potential role in developing, drug resistance. Compared to wild-type PR, PR(F53L) showed lower (15%), catalytic efficiency, 20-fold weaker inhibition by the clinical drug, indinavir, and reduced dimer stability, while the inhibition constants of, two peptide analog inhibitors were slightly lower than those for PR. The, crystal structure of PR(F53L) was determined in the unliganded form at, 1.35 Angstrom resolution in space group P4(1)2(1)2. The tips of the flaps, in PR(F53L) had a wider separation than in unliganded wild-type PR, probably due to the absence of hydrophobic interactions of the side-chains, of Phe53 and Ile50'. The changes in interactions between the flaps agreed, with the reduced stability of PR(F53L) relative to wild-type PR. The, altered flap interactions in the unliganded form of PR(F53L) suggest a, distinct mechanism for drug resistance, which has not been observed in, other common drug-resistant mutants.
<StructureSection load='2g69' size='340' side='right'caption='[[2g69]], [[Resolution|resolution]] 1.35&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[2g69]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2G69 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2G69 FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.35&#8491;</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2g69 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2g69 OCA], [https://pdbe.org/2g69 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2g69 RCSB], [https://www.ebi.ac.uk/pdbsum/2g69 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2g69 ProSAT]</span></td></tr>
</table>
== Function ==
[https://www.uniprot.org/uniprot/Q7SSI0_9HIV1 Q7SSI0_9HIV1]
== Evolutionary Conservation ==
[[Image:Consurf_key_small.gif|200px|right]]
Check<jmol>
  <jmolCheckbox>
    <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/g6/2g69_consurf.spt"</scriptWhenChecked>
    <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>
    <text>to colour the structure by Evolutionary Conservation</text>
  </jmolCheckbox>
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=2g69 ConSurf].
<div style="clear:both"></div>


==About this Structure==
==See Also==
2G69 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Active as [http://en.wikipedia.org/wiki/HIV-1_retropepsin HIV-1 retropepsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.16 3.4.23.16] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2G69 OCA].
*[[Immunodeficiency virus protease 3D structures|Immunodeficiency virus protease 3D structures]]
 
__TOC__
==Reference==
</StructureSection>
Mechanism of drug resistance revealed by the crystal structure of the unliganded HIV-1 protease with F53L mutation., Liu F, Kovalevsky AY, Louis JM, Boross PI, Wang YF, Harrison RW, Weber IT, J Mol Biol. 2006 May 19;358(5):1191-9. Epub 2006 Mar 20. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=16569415 16569415]
[[Category: HIV-1 retropepsin]]
[[Category: Human immunodeficiency virus 1]]
[[Category: Human immunodeficiency virus 1]]
[[Category: Single protein]]
[[Category: Large Structures]]
[[Category: Kovalevsky, A.Y.]]
[[Category: Kovalevsky AY]]
[[Category: Liu, F.]]
[[Category: Liu F]]
[[Category: aspartic protease]]
[[Category: catalysis]]
[[Category: flap mutant]]
[[Category: non-active site mutant]]
[[Category: unliganded]]
 
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Thu Nov  8 14:48:22 2007''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA